cervical ripening. ---
Conditions
Interventions
Intervention 1: In case group, 1000 mg Evening primrose oil (two soft gels) transvaginal, 6 hours before hystroscopy. Intervention 2: In case group, two soft gels of plasebo transvaginal, 6 hours befo
Treatment - Drugs
In case group, 1000 mg Evening primrose oil (two soft gels) transvaginal, 6 hours before hystroscopy
In case group, two soft gels of plasebo transvaginal, 6 hours before hystroscopy
Sponsors
Iran university of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: post -menopausal women with closed cervix, nulliparous and premenopausal women without history of NVD Exclusion criteria: patients with history of NVD, contraindication for use of EPO(bleeding disorder or medication that slow blood clotting, epilepsy ,patient with schizophrenia who receives phenothiazinsphenothiazine) and women with structural anomally of the cervix :incompetent cervix , Mullerian anomally of cervix and history of cervical conization.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total time to get 10 millimeters diameter dilatation of cervix. Timepoint: 6 hours after intervention. Method of measurement: By Chronometer.;What size of dilators need to mid forced insertion. Timepoint: 6 hours after intervention. Method of measurement: By dilator. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complication during insertion of dilators. Timepoint: afrer intervention. Method of measurement: observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Kobra Tahermanesh
Rasool-e-Akram Hospital
Outcome results
None listed